Clinical Manifestation, Laboratory Findings, and the Response of Treatment in Kidney Transplant Recipients With CMV Infection

Transplantation Proceedings

Volumn 39, Issue 4, 2007, Pages 993-996

  Razeghi, E ^a   Hadadi, A ^a   Mansor Kiaei, M ^a   Molavi, M ^a   Khashayar, P ^b   Pourmand, G ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CORTICOSTEROID; CREATININE; GANCICLOVIR;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG PULSE THERAPY; DYSPNEA; FEMALE; FEVER; GRAFT RECIPIENT; HUMAN; INFORMATION SERVICE; KIDNEY TRANSPLANTATION; LABORATORY TEST; LEUKOCYTE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT INFORMATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA; VOMITING;

ADOLESCENT; ADULT; AGED; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 34248536500     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.02.014     Document Type: Article

References (5)

1. Yeung J.S., Tong K.L., and Chan H.W.H. Clinical pattern, risk factors, and outcome of CMV infection in renal transplant recipients: Local experience. Transplant Proc 30 (1998) 3144
2. Geddes C., Church C., Collidge T., et al. Management of cytomegalovirus infection by weekly surveillance after renal transplant: analysis of cost, rejection and renal function. Nephrol Dial Transplant 18 (2003) 1891
3. Nordoy I., Muller F., Nordal K., et al. Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients. J Infect dis 180 (1999) 195
4. Armstrong J., Evans A., Rao N., et al. Viral infections in renal transplant recipients. Infect Immuni 14 (1976) 970
5. Waiser J., Budde K., Schreiber M., et al. Effectiveness of deferred therapy with gancyclovir in renal allograft recipients with cytomegalovirus disease. Transplant Proc 30 (1998) 2083